Search results

  1. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    And it helped you in the past? With which symptoms and about how much improvement?
  2. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    I’m not sure who prevailed in the genetic discussion or whether it was resolved. Regardless of mechanism, a well documented n=1 case history of symptom improvement is always welcome. If the there is an improvement in the more common genotype that means that it is possible spiro might work for...
  3. J

    Imatinib

    I agree with not speculating about mechanisms. Howver, I do think it is important to keep track of anecdotal reports, especially on non-common meds.
  4. J

    Imatinib

    “Just to reiterate: since Imatinib i am still symptomfree (aside from tinnitus), and importantly: my emotional state or mind-body relation or predictive brain relation etc did NOT matter. It is a simple case of less bloodcell activity.”
  5. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    Post in thread 'Spironolactone for viruses - personal experience gathering' https://forums.phoenixrising.me/threads/spironolactone-for-viruses-personal-experience-gathering.84082/post-2427192
  6. J

    Article: We Might Have Long Covid All Wrong (covers FND,ME/CFS,includes Sharpe,Garner, Carson and more).

    Gaffney “There is no society-wide brain degradation occurring because of ongoing mild Covid infections which will continue to the end of time. These accounts cause significant distress for a small but not irrelevant share of the population.”
  7. J

    Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases 2026 Becilli et al

    Abstract Chimeric antigen receptor (CAR) T cell therapy was recently proposed as a treatment for adults with B-cell-mediated autoimmune diseases (ADs) refractory to conventional immunomodulatory therapy. We present a case series of eight children with severe/refractory AD (four systemic lupus...
  8. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    Only one month at 100mg. It seems like she had no response during titration—probably 25, 50, 75 and then 100mg. It seems a little strange that she had no response until she hit exactly 100mg—but life is strange.
  9. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    What is the best commercial kit to test for this gene? Thanks.
  10. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    She suggests eplerenone for men. https://en.wikipedia.org/wiki/Eplerenone
  11. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    Saw this: Note: In some research literature, the C allele (Isoleucine) is the common allele, and G (Valine) is the variant.
  12. J

    Preprint Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report, 2026, Donnellan et al

    The author is the patient. ETA—Oops @forestglip just noted this also.
  13. J

    ME/CFS Silver Linings—Real and Imagined (video)

    Cool video I think alone time ratings will vary a lot depending on the introvert/extrovert level of the person. Regardless of ME/CFS status, introverts tend to find social interactions/excessive stimulation as energy draining—just like ME/CFS itself.
  14. J

    An agentic system for rare disease diagnosis with traceable reasoning, 2026, Zhao et al

    AI succeeds in diagnosing rare diseases An artificial-intelligence system uses clinical data, genetic information and literature searches to suggest diagnoses and provides the underlying reasoning. https://www.nature.com/articles/d41586-026-00290-9 PW
  15. J

    An agentic system for rare disease diagnosis with traceable reasoning, 2026, Zhao et al

    Abstract Rare diseases affect more than 300 million people worldwide1,2,3, yet timely and accurate diagnosis remains an urgent challenge1,3,4,5. Patients often endure a prolonged ‘diagnostic odyssey’ exceeding 5 years, marked by repeated referrals, misdiagnoses and unnecessary interventions...
  16. J

    Immune reset and immune retune: approaching cure? 2026 Isaacs

    Topol is just quoting John Isaacs, the author of the article. He is a professor of clinical rheumatology /RA specialist from New Castle University. Do you know him? https://www.ncl.ac.uk/medical-sciences/people/profile/johnisaacs.html Professor John Isaacs Professor of Clinical Rheumatology...
Back
Top Bottom